Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. Potentially harmful drug–drug interactions in the therapeutic regimens of persons with spinal cord injury

Potentially harmful drug–drug interactions in the therapeutic regimens of persons with spinal cord injury

The Journal of Spinal Cord Medicine, 2024 · DOI: 10.1080/10790268.2023.2185399 · Published: March 8, 2023

Spinal Cord InjuryPharmacologyHealthcare

Simple Explanation

This study looked at the potential for harmful drug interactions in people with spinal cord injuries (SCI) because they often take many medications. The researchers wanted to find out which drug combinations were most likely to cause problems. The study found that almost three out of ten individuals with SCI were at risk of having a potentially harmful drug interaction. The risk was higher for those taking many medications at once. The most common potentially harmful drug combinations involved opioids, gabapentinoids, skeletal muscle relaxants and benzodiazepines. These combinations can increase the risk of serious side effects, such as respiratory depression.

Study Duration
Not specified
Participants
108 individuals with spinal cord injury
Evidence Level
Observational design and cross-sectional analysis

Key Findings

  • 1
    Almost three out of ten individuals with spinal cord injury were at risk of having a potentially harmful drug interaction.
  • 2
    The risk of having a potential DDI was highly associated with polypharmacy.
  • 3
    The top 3 prevalent DDIs were Opioids + Skeletal Muscle Relaxants, Opioids + Gabapentinoids, and Benzodiazepines + ≥2 other central nervous system (CNS)-active drugs.

Research Summary

This study aimed to identify common, potentially harmful drug interactions in individuals with spinal cord injury (SCI) and associated risk factors. The study found that almost three out of ten individuals with SCI were at risk of experiencing a potentially harmful drug interaction, with polypharmacy being a significant risk factor. The most prevalent potential drug-drug interactions involved opioids combined with skeletal muscle relaxants or gabapentinoids, and benzodiazepines with other CNS-active drugs. These combinations can lead to serious adverse effects.

Practical Implications

Clinical Tool Development

Creation of tools to identify and eliminate harmful drug combinations in SCI patients' therapeutic regimens.

Enhanced Communication

Improve communication between patients and prescribers regarding potential drug interactions.

Integrated Pharmacy Services

Incorporating pharmacists into interdisciplinary primary care teams to manage medications and screen for drug interactions.

Study Limitations

  • 1
    Results are based on self-reported data and are not validated against patients’ medical records.
  • 2
    The study assessed for 20 selected drug combinations, potentially missing other drug interactions.
  • 3
    Data were collected using an online survey, this method may have excluded those who do not use the internet.

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury